Practical guidance for delivering radical cure safely, aimed at national malaria programs and laboratory teams. Covers the full case-management pathway: diagnosis, G6PD testing and the interpretation of quantitative, semi-quantitative and qualitative results, treatment options including tafenoquine and primaquine regimens, and the operational requirements — training, quality control, pharmacovigilance and supervision — needed to introduce G6PD testing into routine services. The WHO recommendation on tafenoquine applies to South America, making this guidance directly relevant to the region.

Resource type: Technical guidance
Organization: World Health Organization
Languages: English, Spanish (published by PAHO)
https://iris.who.int/handle/10665/384936
Spanish version: https://doi.org/10.37774/9789275331910